INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 132 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $434,000 | -27.5% | 16,916 | -27.5% | 0.00% | 0.0% |
Q2 2020 | $599,000 | +9.1% | 23,328 | -34.7% | 0.00% | 0.0% |
Q1 2020 | $549,000 | -46.6% | 35,728 | +19.1% | 0.00% | 0.0% |
Q4 2019 | $1,029,000 | +433.2% | 30,000 | +101.3% | 0.00% | – |
Q2 2019 | $193,000 | +11.6% | 14,900 | +4.9% | 0.00% | – |
Q1 2019 | $173,000 | +6.8% | 14,200 | 0.0% | 0.00% | – |
Q4 2018 | $162,000 | -64.6% | 14,200 | -32.7% | 0.00% | -100.0% |
Q3 2018 | $458,000 | -31.2% | 21,100 | -44.0% | 0.00% | 0.0% |
Q2 2018 | $666,000 | -35.6% | 37,700 | -23.2% | 0.00% | -50.0% |
Q1 2018 | $1,034,000 | +353.5% | 49,100 | +250.7% | 0.00% | – |
Q1 2017 | $228,000 | -1.3% | 14,000 | -8.5% | 0.00% | – |
Q4 2016 | $231,000 | +6.9% | 15,300 | +7.7% | 0.00% | – |
Q3 2016 | $216,000 | – | 14,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
RA Capital Management | 314,349 | $12,587,000 | 1.81% |
WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |